Ignite Creation Date:
2024-05-05 @ 11:26 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00046683
Status:
COMPLETED
Last Update Posted:
2016-07-28
First Post:
2002-10-01
Brief Title:
EfficacySafety of Frontline Alemtuzumab Campath MabCampath vs Chlorambucil in Patients With Progressive B-Cell Lymphocytic Leukemia
Sponsor:
Genzyme a Sanofi Company
Organization:
Sanofi